Maia Biotechnology Stock Analysis
| MAIA Stock | USD 2.00 0.01 0.50% |
MAIA Biotechnology is undervalued with Real Value of 4.43 and Target Price of 11.75. The main objective of MAIA Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what MAIA Biotechnology is worth, separate from its market price. There are two main types of MAIA Biotechnology's stock analysis: fundamental analysis and technical analysis.
The MAIA Biotechnology stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MAIA Biotechnology's ongoing operational relationships across important fundamental and technical indicators.
MAIA |
MAIA Stock Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.34. MAIA Biotechnology had not issued any dividends in recent years. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. The company was founded in 2018 and is headquartered in Chicago, Illinois. Maia Biotechnology operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 9 people. To find out more about MAIA Biotechnology contact the company at 312 416 8592 or learn more at https://maiabiotech.com.MAIA Biotechnology Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MAIA Biotechnology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MAIA Biotechnology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| MAIA Biotechnology generated a negative expected return over the last 90 days | |
| MAIA Biotechnology has high historical volatility and very poor performance | |
| MAIA Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MAIA Biotechnology currently holds about 8.15 M in cash with (13.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| MAIA Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Guerrero Ramiro of 53418 shares of MAIA Biotechnology at 2.08 subject to Rule 16b-3 |
MAIA Biotechnology Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MAIA Biotechnology previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
MAIA Largest EPS Surprises
Earnings surprises can significantly impact MAIA Biotechnology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-14 | 2024-03-31 | -0.39 | -0.46 | -0.07 | 17 | ||
2024-11-14 | 2024-09-30 | -0.47 | -0.11 | 0.36 | 76 |
MAIA Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.66 M.MAIA Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.61) | (2.74) | |
| Return On Capital Employed | (7.67) | (7.29) | |
| Return On Assets | (2.61) | (2.74) | |
| Return On Equity | (41.41) | (39.34) |
Management Efficiency
MAIA Biotechnology has return on total asset (ROA) of (1.0711) % which means that it has lost $1.0711 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5956) %, meaning that it created substantial loss on money invested by shareholders. MAIA Biotechnology's management efficiency ratios could be used to measure how well MAIA Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of December 16, 2024, Return On Tangible Assets is expected to decline to -2.74. The current year's Return On Capital Employed is expected to grow to -7.29. At present, MAIA Biotechnology's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.59, whereas Total Assets are forecasted to decline to about 7.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.04 | 0.03 | |
| Tangible Book Value Per Share | 0.04 | 0.03 | |
| Enterprise Value Over EBITDA | (0.41) | (0.39) | |
| Price Book Value Ratio | 32.49 | 34.12 | |
| Enterprise Value Multiple | (0.41) | (0.39) | |
| Price Fair Value | 32.49 | 34.12 | |
| Enterprise Value | 8.4 M | 7.9 M |
The operational strategies employed by MAIA Biotechnology management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 0.34 | Return On Assets (1.07) | Return On Equity (5.60) |
Technical Drivers
As of the 16th of December 2024, MAIA Biotechnology secures the Standard Deviation of 4.42, mean deviation of 3.39, and Market Risk Adjusted Performance of 6.17. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MAIA Biotechnology, as well as the relationship between them.MAIA Biotechnology Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MAIA Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MAIA Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MAIA Biotechnology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MAIA Biotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on MAIA Biotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MAIA Biotechnology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MAIA Biotechnology Predictive Daily Indicators
MAIA Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MAIA Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MAIA Biotechnology Forecast Models
MAIA Biotechnology's time-series forecasting models are one of many MAIA Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MAIA Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MAIA Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MAIA Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MAIA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MAIA Biotechnology. By using and applying MAIA Stock analysis, traders can create a robust methodology for identifying MAIA entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current MAIA Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MAIA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MAIA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 11.75 | Strong Buy | 1 | Odds |
Most MAIA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MAIA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MAIA Biotechnology, talking to its executives and customers, or listening to MAIA conference calls.
MAIA Stock Analysis Indicators
MAIA Biotechnology stock analysis indicators help investors evaluate how MAIA Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MAIA Biotechnology shares will generate the highest return on investment. By understating and applying MAIA Biotechnology stock analysis, traders can identify MAIA Biotechnology position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 11 M | |
| Total Stockholder Equity | 477.5 K | |
| Cash And Short Term Investments | 7.2 M | |
| Net Invested Capital | 477.5 K | |
| Shares Float | 19.5 M | |
| Cash | 7.2 M | |
| 200 Day M A | 2.814 | |
| 50 Day M A | 2.4593 | |
| Net Interest Income | 27.6 K | |
| Total Current Liabilities | 4.9 M | |
| Interest Expense | 6863.00 | |
| Stock Based Compensation | 3.1 M | |
| Common Stock Shares Outstanding | 13.3 M | |
| Free Cash Flow | -13.1 M | |
| Operating Income | -20.2 M | |
| Other Current Assets | 268.7 K | |
| Accounts Payable | 1.6 M | |
| Net Debt | -7.2 M | |
| Accumulated Other Comprehensive Income | -16.3 K | |
| Other Operating Expenses | 20.2 M | |
| Non Current Assets Total | 2800.00 | |
| Total Current Assets | 7.6 M | |
| Liabilities And Stockholders Equity | 7.6 M | |
| Non Currrent Assets Other | 2800.00 |
Complementary Tools for MAIA Stock analysis
When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |